•  
  •  
 

Bulletin of Chinese Academy of Sciences (Chinese Version)

Keywords

synthetic biology; industrial development; development path; policy guarantee

Document Type

Biomanufacturing: Retrospect and Prospects

Abstract

Synthetic biology is hailed as the third revolution in life sciences after the discovery of the DNA double helix structure and genomic technology, and is the core driving force for the leapfrog development of next-generation biomanufacturing and the future bioeconomy, opening up an opportunity window for the reshaping of the global manufacturing map. How to strategically position the synthesis biology industry and seize the strategic high ground in the industry is a core topic of interest for global science and technology powers and manufacturing powers. Based on the identification of problems in the development of China’s synthesis biology industry, this study draws on the experience of typical countries and takes integration and transformation as the theme to design dual innovation paths of organized innovation fusion and value-added transformation fusion for the synthesis biology industry, and proposes policy support measures from the perspectives of improving the development mechanism of the synthesis biology industry, strengthening the policy support system for the development of synthesis biology, exploring the classification entry and market access system for synthesis biology products, and improving the regulatory system and mechanism for synthesis biology.

First page

127

Last Page

139

Language

Chinese

Publisher

Bulletin of Chinese Academy of Sciences

References

1 中国学科及前沿领域发展战略研究（2021—2035）项目组. 中国合成生物学2035发展战略. 北京: 科学出版社, 2023. Research on the Development Strategy of Chinese Disciplines and Frontier Fields (2021—2035) Project Team. China Synthetic Biology 2035 Development Strategy. Beijing: Science Press, 2023. (in Chinese)

2 合成生物学发展战略研究组. 合成生物学路线图2030. 北京: 科学出版社, 2024. Synthetic Biology Development Strategy Group. Synthetic Biology Roadmap 2030. Beijing: Science Press, 2024. (in Chinese)

3 马悦, 汪哲, 薛淮, 等. 中英美三国合成生物学科技规划和产业发展比较分析. 生命科学, 2021, 33(12): 1560-1566. Ma Y, Wang Z, Xue H, et al. Comparative analysis of scientific and technological strategic planning and industrial development of synthetic biology among China, Britain and America. Chinese Bulletin of Life Sciences, 2021, 33(12): 1560-1566. (in Chinese)

4 罗楠, 赵国屏, 刘陈立. 合成生物学的科学问题. 生命科学, 2021, 33(12): 1429-1435. Luo N, Zhao G P, Liu C L. Scientific questions in synthetic biology. Chinese Bulletin of Life Sciences, 2021, 33(12): 1429-1435. (in Chinese)

5 曾艳, 赵心刚, 周桔. 合成生物学工业应用的现状和展望. 中国科学院院刊, 2018, 33(11): 1211-1217. Zeng Y, Zhao X G, Zhou J. Current situations and perspectives of industrial applications of synthetic biology. Bulletin of Chinese Academy of Sciences, 2018, 33(11): 1211-1217. (in Chinese)

6 赵国屏. 合成生物学：从“造物致用”到产业转化. 生物工程学报, 2022, 38(11): 4001-4011. Zhao G P. Synthetic biology: From “build-for-use” to commercialization. Chinese Journal of Biotechnology, 2022, 38(11): 4001-4011. (in Chinese)

7 张媛媛, 曾艳, 王钦宏. 合成生物制造进展. 合成生物学, 2021, 2(2): 145-160. Zhang Y Y, Zeng Y, Wang Q H. Advances in synthetic biomanufacturing. Synthetic Biology Journal, 2021, 2(2): 145-160. (in Chinese)

8 张先恩. 中国合成生物学发展回顾与展望. 中国科学：生命科学, 2019, 49(12): 1543-1572.Zhang X E. Synthetic biology in China: Review and prospects. Scientia Sinica Vitae, 2019, 49(12): 1543-1572. (in Chinese)

9 韩祺, 姜江, 汪琪琦, 等. 我国工业生物技术和产业的现状、差距与任务. 生物工程学报, 2022, 38(11): 4035-4042.Han Q, Jiang J, Wang Q Q, et al. The current situation and developmental trends of industrial biotechnology and biomanufacturing in China. Chinese Journal of Biotechnology, 2022, 38(11): 4035-4042. (in Chinese)

10 崔金明, 张炳照, 马迎飞, 等. 合成生物学研究的工程化平台. 中国科学院院刊, 2018, 33(11): 1249-1257.Cui J M, Zhang B Z, Ma Y F, et al. Engineering platforms for synthetic biology research. Bulletin of Chinese Academy of Sciences, 2018, 33(11): 1249-1257. (in Chinese)

11 赵国屏. 合成生物学的科学内涵和社会意义——合成生物学专刊序言. 生命科学, 2011, 23(9): 825.Zhao G P. Scientific connotation and social significance of synthetic biology: Preface of special issue on synthetic biology. Scientia Sinica Vitae, 2011, 23(9): 825. (in Chinese)

12 周光明, 陈大明, 熊燕, 等. 英国合成生物学规划及其影响与启示. 中国细胞生物学学报, 2019, 41(11): 2091-2100. Zhou G M, Chen D M, Xiong Y, et al. UK synthetic biology strategic planning and its enlightenment. Chinese Journal of Cell Biology, 2019, 41(11): 2091-2100. (in Chinese)

13 钱万强, 江海燕, 朱庆平, 等. 国内外合成生物学资助体系及产业投入分析. 中国基础科学, 2014, 16(1): 47-50. Qian W Q, Jiang H Y, Zhu Q P, et al. Analysis of the funding systems and industry investment of synthetic biology in China and main developed countries. Chinese Basic Science, 2014, 16(1): 47-50. (in Chinese)

14 张特, 陈若彤, 张兮, 等. 合成生物学研发的风险类型分析——基于Meta的分析. 科学与社会, 2022, 12(3): 33-61. Zhang T, Chen R T, Zhang X, et al. Biosafety risk factors of synthetic biology research and application. Science and Society, 2022, 12(3): 33-61. (in Chinese)

15 孔青青, 徐飞. 机体哲学视域下的合成生物技术风险析因及治理. 自然辩证法研究, 2023, 39(7): 70-75. Kong Q Q, Xu F. Risk analysis and management of synthetic biotechnology from the perspective of organism philosophy. Studies in Dialectics of Nature, 2023, 39(7): 70-75. (in Chinese)

16 林敏, 姚斌. 加强合成生物技术创新，引领现代农业跨越发展. 生物技术进展, 2022, 12(3): 321-324. Lin M, Yao B. Strengthening innovation in synthetic biotechnology and leading the leapfrog development of modern agriculture. Current Biotechnology, 2022, 12(3): 321-324. (in Chinese)

17 王伟伟, 蒋建东, 唐鸿志, 等. 环境遇见合成生物学. 生命科学, 2021, 33(12): 1544-1550. Wang W W, Jiang J D, Tang H Z, et al. Environmental monitoring and bioremediation meet synthetic biology. Chinese Bulletin of Life Sciences, 2021, 33(12): 1544-1550. (in Chinese)

18 周文娟, 付刚, 齐显尼, 等. 发酵工业菌种的迭代创制. 生物工程学报, 2022, 38(11): 4200-4218. Zhou W J, Fu G, Qi X N, et al. Upgrading microbial strains for fermentation industry. Chinese Journal of Biotechnology, 2022, 38(11): 4200-4218. (in Chinese)

19 毕心宇, 吕雪芹, 刘龙, 等. 我国微生物制造产业的发展现状与展望. 中国工程科学, 2021, 23(5): 59-68. Bi X Y, Lyu X Q, Liu L, et al. Development status and prospects of microbial manufacturing industry in China. Strategic Study of Chinese Academy of Engineerng, 2021, 23(5): 59-68. (in Chinese)

20 张拓宇, 孟庆海. 基于产业视角的合成生物学发展态势研究. 世界科技研究与发展, 2024, 46(1): 58-71. Zhang T Y, Meng Q H. Trend analysis of synthetic biology in industry perspective. World SCI-TECH R&D, 2024, 46(1): 58-71. (in Chinese)

21 高歌, 边旗, 王宝俊. 合成基因线路的工程化设计研究进展与展望. 合成生物学, 2024, doi: 10.12211/2096-8280.2023-096. Gao G, Bian Q, Wang B J. Progress and prospect of engineering design of synthetic gene circuits. Synthetic Biology Journal, 2024, doi: 10.12211/2096-8280.2023-096.(in Chinese)

22 刘晓, 汪哲, 陈大明, 等. 合成生物学时代的生物安全治理. 科学与社会, 2022, 12(3): 1-14.Liu X, Wang Z, Chen D M, et al. Biosafety and biosecurity governance in the era of synthetic biology. Science and Society, 2022, 12(3): 1-14. (in Chinese)

23 李振兴. 英国合成生物学发展重点研究. 全球科技经济瞭望, 2013, 28(11): 26-30. Li Z X. Study on priorities of development of synthetic biology in the UK. Global Science, Technology and Economy, 2013, 28(11): 26-30. (in Chinese)

24 刘晓, 曾艳, 王力为, 等. 创新政策体系保障合成生物学科技与产业发展. 中国科学院院刊, 2018, 33(11): 1260-1268. Liu X, Zeng Y, Wang L W, et al. Innovative policy system to ensure the development of synthetic biology. Bulletin of Chinese Academy of Sciences, 2018, 33(11): 1260-1268. (in Chinese)

25 朱菊隐, 展进涛. 合成生物学科技风险的管理与规制：国际防范逻辑与中国应对策略. 科技管理研究, 2023, 43(10): 36-42. Zhu J Y, Zhan J T. Management and regulation of scientific and technological risks in synthetic biology: International preventive logic and China’s response strategy. Science and Technology Management Research, 2023, 43(10): 36-42. (in Chinese)

26 曾小美, 朱泽熙, 翁俊. 合成生物学产品商业化安全监管思考. 生物工程学报, 2024, 40(3): 758-772. Zeng X M, Zhu Z X, Weng J. Reflections on the safety regulation of commercialization of synthetic biology products. Chinese Journal of Biotechnology, 2024, 40(3): 758-772. (in Chinese)

27 陈大明, 朱成姝, 汪哲, 等. 生物合成科技与应用的监管. 科学通报, 2023, 68(19): 2457-2469. Chen D M, Zhu C S, Wang Z, et al. Regulation and regulatory science for biosynthetic science, technology and applications. Chinese Science Bulletin, 2023, 68(19): 2457-2469. (in Chinese)

Download
Request a Copy

Share

COinS